Clinical Trial Update: Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury

View source ↗

Summary

This clinical trial completed a study evaluating novel biomarkers in acutely ill patients at risk for acute kidney injury. The sponsor is Astute Medical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Astute Medical, Inc. | Conditions: Acute Kidney Injury | Status: COMPLETED